ACIP Recommends Merck's RSV Vaccine for Infants Under 8 Months

ACIP Vote on Merck's RSV Vaccine

• 🎯 The ACIP committee voted 5 to 2 to recommend Merck's RSV shot for babies under 8 months old.
• ⚠️ A new committee member raised safety concerns regarding an imbalance in infant deaths observed in clinical trial data.
• 💬 This led to a discussion where other members highlighted the vaccines as breakthroughs for protecting infants from a serious virus.

Upcoming Votes and ACIP Agenda

• 🗓️ The ACIP has several more votes scheduled for the day, including those related to flu shots.
• 🧪 A debate is expected regarding thymerosal, an additive in flu shots, though it's generally considered a settled safety issue.
• 🔄 The new chairman of the ACIP plans to review the current childhood immunization schedule and re-evaluate vaccines not reviewed in over seven years.